Resultado de búsqueda
17 de may. de 2024 · Respiri is a healthtech company providing devices and mobile apps for the management of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease.
8 de may. de 2024 · Respiri Limited is an Australia-based e-health software as a service company that supports respiratory health management. It is engaged in research, development and commercialization of medical...
22 de may. de 2024 · Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal.
7 de may. de 2024 · Respiri Limited (ASX: RSH) - Share Price and Research. - Current share price for RSH : $0.032. Respiri Limited (RSH, formerly iSonea Limited), an ASX-listed company, is an international e-Health SaaS company supporting respiratory health management focusing primarily on supporting the US remote patient monitoring market.
22 de may. de 2024 · Respiri Limited is an Australia-based e-health software as a service company that supports respiratory health management. It is engaged in research, development and commercialization of medical...
15 de may. de 2024 · Spiriva Respimat. 2, 5 mcg / pulverización. Solución para inhalación. Medicamento en forma farmaceútica de tipo solución para inhalación, se administra por vía inhalatoria, compuesto por 3.124 µg del principio activo Bromuro de tiotropio monohidrato. Contiene los excipientes Cloruro de benzalconio (1.105µg), Edetato de disodio (1.105µg).
Hace 2 días · Free stock charts, prices, volume, market data, history, options flow, news, seasonality and more for RSHUF (Respiri ltd) on TrendSpider
